Search - tctmd.com

Displaying 81 - 100 of 284

Sort: Relevancy | Date

News Daily News

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Michael O'Riordan

September 24, 2020

In-Stent Restenosis Accounts for 10% of All PCIs, Contemporary National Analysis Shows

News Daily News

In-Stent Restenosis Accounts for 10% of All PCIs, National Analysis Shows

L.A. McKeown

September 24, 2020

News Daily News

Increased Lifetime Exposure to High LDL Cholesterol Predicts ASCVD

Michael O'Riordan

September 22, 2020

News Daily News

Recurrent Events After MI Show Enduring Gender, Racial Gaps in Care

Shelley Wood

September 22, 2020

News Daily News

ABC-Bleeding Score Stratifies Risk in A-fib Patients on OAC and Aspirin

Todd Neale

September 21, 2020

News Daily News

Postmenopausal Women See Added ASCVD Risk After Complicated Pregnancies

Caitlin E. Cox

September 18, 2020

News Daily News

US Cath Labs and COVID-19: Pushed Procedures, Late STEMIs, and Paycheck Pain

Shelley Wood

September 17, 2020

News Daily News

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

Michael O'Riordan

September 16, 2020

News Daily News

PCI Volumes Rise in US and Japan, but for Different Reasons

Michael O'Riordan

September 14, 2020

News Daily News

LDL Cholesterol Control Post-PCI Is Low and Linked to Worse Outcomes

Yael L. Maxwell

September 14, 2020

News Daily News

Which TAVR Device Is Best? Review Tackles Optimal Selection

Michael O'Riordan

September 09, 2020

News Daily News

Barriers to Flu Shot in ASCVD Patients: Age, Race, Healthcare Access

Caitlin E. Cox

September 09, 2020

News Conference News ESC 2020

Insights From a Deep Dive Into CV Risk Among Hospitalized COVID-19 Patients

Shelley Wood

September 04, 2020

News Conference News ESC 2020

COVID-19 Blamed for Weaker Research Published by Top-Tier Journals in 2020

Michael O'Riordan

September 04, 2020

News Conference News ESC 2020

VOYAGER PAD: CAD Subanalysis Finds Fewer CV, Limb Events With Rivaroxaban

L.A. McKeown

September 03, 2020

News Conference News ESC 2020

New European NSTE ACS Guidelines Embrace hs-Troponin, CTA, NOAC Trials

Caitlin E. Cox

September 03, 2020

News Daily News

Free CAC Scans for ASCVD Risk Capture More Women, Minorities, and Low-Income Adults

Michael O'Riordan

September 02, 2020

News Industry News

Cardiac Dimensions Announces Australian Therapeutic Goods Administration's Approval of the Carillon System for the Treatment of Functional Mitral Regurgitation

September 02, 2020

News Opinion CV Team Dispatch

September 2020 News Roundup

L.A. McKeown

September 01, 2020

News Conference News ESC 2020

In Long-term, Real-world Data, CABG Bests PCI for Diabetic Patients With MVD

Yael L. Maxwell

September 01, 2020

Advertisement

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

In-Stent Restenosis Accounts for 10% of All PCIs, National Analysis Shows

Increased Lifetime Exposure to High LDL Cholesterol Predicts ASCVD

Recurrent Events After MI Show Enduring Gender, Racial Gaps in Care

ABC-Bleeding Score Stratifies Risk in A-fib Patients on OAC and Aspirin

Postmenopausal Women See Added ASCVD Risk After Complicated Pregnancies

US Cath Labs and COVID-19: Pushed Procedures, Late STEMIs, and Paycheck Pain

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

PCI Volumes Rise in US and Japan, but for Different Reasons

LDL Cholesterol Control Post-PCI Is Low and Linked to Worse Outcomes

Which TAVR Device Is Best? Review Tackles Optimal Selection

Barriers to Flu Shot in ASCVD Patients: Age, Race, Healthcare Access

Insights From a Deep Dive Into CV Risk Among Hospitalized COVID-19 Patients

COVID-19 Blamed for Weaker Research Published by Top-Tier Journals in 2020

VOYAGER PAD: CAD Subanalysis Finds Fewer CV, Limb Events With Rivaroxaban

New European NSTE ACS Guidelines Embrace hs-Troponin, CTA, NOAC Trials

Free CAC Scans for ASCVD Risk Capture More Women, Minorities, and Low-Income Adults

Cardiac Dimensions Announces Australian Therapeutic Goods Administration's Approval of the Carillon System for the Treatment of Functional Mitral Regurgitation

September 2020 News Roundup

In Long-term, Real-world Data, CABG Bests PCI for Diabetic Patients With MVD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content